PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.87
ESG score 80-90% of INKT's 68.97. Walter Schloss would scrutinize governance quality and regulatory exposure.
50.00
Environmental score 80-90% of INKT's 59.45. Walter Schloss would scrutinize carbon exposure and transition planning.
61.14
Social score below 80% of INKT's 76.83. Jim Chanos would check for potential social license and litigation risks.
68.48
Similar governance score to INKT's 70.64. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.